(S)-1-((4-(2-((2-Aminoethyl)disulfanyl)ethoxy)-3-methoxyphenethyl)amino)-3-(naphthalen-1-yloxy)propan-2-ol

ID: ALA4537221

PubChem CID: 155548437

Max Phase: Preclinical

Molecular Formula: C26H34N2O4S2

Molecular Weight: 502.70

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(CCNC[C@H](O)COc2cccc3ccccc23)ccc1OCCSSCCN

Standard InChI:  InChI=1S/C26H34N2O4S2/c1-30-26-17-20(9-10-25(26)31-14-16-34-33-15-12-27)11-13-28-18-22(29)19-32-24-8-4-6-21-5-2-3-7-23(21)24/h2-10,17,22,28-29H,11-16,18-19,27H2,1H3/t22-/m0/s1

Standard InChI Key:  ZBAVHTZBLFYIAR-QFIPXVFZSA-N

Molfile:  

 
     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
   23.6490   -2.4186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3609   -2.0100    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.0727   -2.4186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7845   -2.0100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4964   -2.4186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7845   -1.1886    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.2041   -2.0100    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.9159   -2.4186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6277   -2.0100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2258   -3.2371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9427   -3.6497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6511   -3.2353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2263   -2.4150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9356   -2.0095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9360   -1.1938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2279   -0.7826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5220   -1.1972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5250   -2.0115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3396   -2.4186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3377   -3.2409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0487   -3.6536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7615   -3.2408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7589   -2.4153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0473   -2.0104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4693   -2.0042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.4739   -3.6526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.4664   -1.1829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1852   -3.2389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8935   -3.6507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6047   -3.2370    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   34.3171   -3.6488    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   35.0284   -3.2352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7408   -3.6469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4521   -3.2333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  1
  5  7  1  0
  7  8  1  0
  8  9  1  0
  1 14  2  0
 13 10  2  0
 10 11  1  0
 11 12  2  0
 12  1  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  9 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 23 25  1  0
 22 26  1  0
 25 27  1  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4537221

    ---

Associated Targets(Human)

ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adrb1 Beta-1 adrenergic receptor (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 502.70Molecular Weight (Monoisotopic): 502.1960AlogP: 4.14#Rotatable Bonds: 16
Polar Surface Area: 85.97Molecular Species: BASEHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.79CX LogP: 3.38CX LogD: -0.67
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.20Np Likeness Score: -0.34

References

1. Schwalbe T, Huebner H, Gmeiner P..  (2019)  Development of covalent antagonists for β1- and β2-adrenergic receptors.,  27  (13): [PMID:31151791] [10.1016/j.bmc.2019.05.034]

Source